CWBR Share Price Performance
US$0.41
-0.12 (-22.64%)
Price US$0.41
Share PriceUS$0.41
CWBR Community Narratives
There are no narratives available yet.
Recent CWBR News & Updates
CohBar, Inc. Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
CohBar, Inc. Competitors
Snowflake Analysis
About CWBR
- Founded
- 2007
- Employees
- n/a
- CEO
- WebsiteView website
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
U.S. Market Performance
- 7 Days: -1.6%
- 3 Months: 9.8%
- 1 Year: 15.1%
- Year to Date: 8.0%
Over the last 7 days, the market has dropped 1.6%, driven by a loss of 3.6% in the Information Technology sector. In the last year, the market is actually up 15%. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›